{
    "title": "Drugmakers' shares stabilise after Zantac litigation slump",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11105577/Drugmakers-shares-stabilise-Zantac-litigation-slump.html",
    "date": "2022-08-12",
    "keywords": [
        "haleon",
        "gsk",
        "sanofi",
        "pfizer",
        "litigation",
        "week",
        "grover",
        "friday",
        "month",
        "risk",
        "market",
        "bayer",
        "reporting",
        "nothing",
        "material",
        "drug",
        "share",
        "investor",
        "concern",
        "cancercausing",
        "trial",
        "prospect",
        "prospectus",
        "value",
        "absence",
        "catalyst",
        "note",
        "start",
        "forerunner",
        "loss",
        "patent",
        "exclusivity",
        "boehringer",
        "ingelheim",
        "company",
        "consumer",
        "health",
        "uncertainty",
        "outcome",
        "worsecase",
        "scenario",
        "merck",
        "amp",
        "cos",
        "painkiller",
        "vioxx",
        "weedkiller",
        "pharma",
        "memory",
        "experience",
        "companys",
        "healthcare",
        "sector",
        "case",
        "reaction",
        "sell",
        "sense",
        "morning",
        "joice",
        "mathew",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}